Skip to content

13F-HR filed by M28 Capital Management LP

M28 Capital Management LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-14, with 11 holding rows worth $135,332,878.

Accession
0000902664-24-003553
Filed
2024-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 11 entries on the cover page, a total value of $135,332,878 stated on the cover page (in dollars after the unit check, H1), rows summing to $135,332,878 with VALUE read as dollars as filed, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WAVE LIFE SCIENCES LTD SHSY95308105Stock7,000,000$43,190,000dollars as filed
INVIVYD INC00534A102COMMON STOCK9,248,250$41,062,230dollars as filed
FRACTYL HEALTH INC35168W103COM1,856,117$13,735,266dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM385,680$10,390,219dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS299,400$6,467,040dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM110,400$5,433,888dollars as filed
CURIS INC231269309COM421,951$4,586,607dollars as filed
BRIDGEBIO PHARMA INC10806X102COM121,200$3,747,504dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock161,600$2,457,936dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO1,019,498$2,334,548dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM67,400$1,927,640dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-24-003553this filing2024-05-14acceptance time not in the bulk data set